CNE receives record number of job applications amid high youth unemployment
The CNE says it has received more than 54,000 online job applications for more than 5,000 seasonal positions at the two-week fair, including cashiers, retail associates, game attendants, food service staff, midway operators and informational guides.
It says this is the highest number of job applications it has ever received, calling it a reflection of a job market that's causing high rates of youth unemployment.
One expert says the youth unemployment rate is higher this year compared to the same period last year but it's still lower than during the COVID-19 pandemic and the 2008 recession.
Viet Vu, the manager of economic research at Toronto Metropolitan University's Dais think thank, says youth unemployment is up because the job market has cooled over the last several months, due to fewer businesses hiring and the disruptions in trade with the United States.
The seasonally adjusted unemployment rate for people aged 15 to 24 in Ontario was 15.8 per cent in June.
Vu says a lot of young people who are looking for their first job after graduation and students who are looking for summer jobs are hit especially hard in a difficult job market.
Monday Mornings
The latest local business news and a lookahead to the coming week.
The CNE says it has already hired people for more than 1,000 positions.
This report by The Canadian Press was first published July 30, 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Global News
15 hours ago
- Global News
Canada's housing market is in ‘new normal.' It looks like the ‘old normal'
With the Bank of Canada holding interest rates again, economists and real estate experts say the housing market's 'new normal' may be looking more and more like the 'old normal' from before the COVID-19 pandemic. 'What we have now with more supply in the market, like more inventory, homes for sale, and this is what I would consider a little bit more — not everywhere in Canada — but generally speaking more return to the old normal before the pandemic,' said Robert Hogue, assistant chief economist at RBC. 'Actually, probably a lot more before the pandemic with a bit more time for buyers to make decisions.' Much of the original hesitation from buyers waiting to enter the market in early 2025 was due to the uncertainty of looming and implemented tariffs by the U.S., Hogue said. Story continues below advertisement He added in the months since, the perspectives of Canadians have changed and the lack of 'doom and gloom' is bringing back some homebuyers. National home sales rose 2.8 per cent in June, building on a 3.5-per cent rise in May, the Canadian Real Estate Association (CREA) said earlier this month. However, the CREA's senior economist, Shaun Cathcart, cautioned while homes sales saw a boost — including a 17.3-per cent rebound in the Greater Toronto Area since April — the national picture is a 'carbon copy' from May sales figures. 2:39 Peterborough housing market shows slow spring Hogue notes that positivity and growing confidence will benefit the housing market in the long-term, especially as RBC does not expect any further rate cuts. Get breaking National news For news impacting Canada and around the world, sign up for breaking news alerts delivered directly to you when they happen. Sign up for breaking National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy There are still some challenges, such as continued U.S. uncertainty, but he said some energy is returning. Story continues below advertisement 'What we've seen in recent months is a return to that recovery is still very kind of gentle, just more of a turning point taking place,' he said. 'Barring any major bad news on the trade front that would send more kind of ice cold water on expectations and confidence, we should see that recovery going forward.' Some mortgage brokers in Canada say despite concerns over U.S. tariffs and the economy, they're still seeing people entering the market. 'Every mortgage broker that I speak to is busy right now because house prices are high, interest rates aren't great but people are still buying,' said Hannah Martens, mortgage broker and president of the Canadian Mortgage Brokers Association Atlantic. 'I really do feel that even though we aren't in a perfect market right now, and I don't think there will ever be a perfect market, people, if they're ready, then should come into the market whenever they're ready.' Affordability remains a 'psychological' block Even with Canadians trying to buy their first or a new home, there are still barriers and affordability may be a key factor. Story continues below advertisement 'We still have affordability issues, but I think even for those who have the ability to purchase right now, they're not. We need them to pull the trigger,' said Mary Sialtsis, a licensed mortgage broker in Ontario. 'Maybe it does take the Bank of Canada to start dropping the prime lending rate because it is that psychological impact, because I do have buyer clients out there actively shopping right now, but they're not actually pulling the trigger and making an offer.' Sialtsis said what may be needed even more is an adjustment of expectations. 'I know that some of the buyers that are out there shopping are just thinking, 'Well, you know, I'll wait until I can get a better deal,' and it starts to become unreasonable,' she said. 1:01 Throne speech: King Charles says Liberals will work to make Canada's housing market 'work better' 'For sellers, I really think they need to adjust their expectations and they need to, I'm sure their realtors are advising them of what comparable sales are in their neighbourhood, they need to adjust their expectations accordingly.' Story continues below advertisement Canadians hoping for low mortgage rates seen during the COVID-19 pandemic may be out of luck, but Royal LePage's Anne-Elise C. Allegritti said some people appear to be realizing this. 'I think Canadians have adapted to this sort of, being roughly the new normal in terms of borrowing rates. Could they go down a little bit more, sure, but I don't think anyone is expecting them to reach those rock-bottom rates that we saw during COVID and that's a good thing,' said Allegritti, director of research and communications at Royal LePage. 'I think sometimes our perspective can be skewed because of this extreme that we experienced not too long ago and this feels now like the opposite extreme, but it really is a leveling off.'
Canada News.Net
a day ago
- Canada News.Net
Trump fires head of statistics bureau after poor jobs report
In an extraordinary outburst, U.S. President Donald Trump, aside from lambasting Federal Reserve Cahir Jay Powell, has now taken aim at the head of the bureau overseeing the tabulation of employment statistics, following Friday's disappointing jobs report. On Friday, the Bureau of Labor Statistics reported that the U.S. economy added just 73,000 jobs in July, far less than expected, and revised down the May and June figures, by a combined 258,000 jobs. A furious Donald Trump took to Truth Social, his own social media platform, to blast the bureau chief, and fire her, claiming she was 'faking' the stistics, and noting she was appointed by long time rival, former President Joe Biden. She was nominated by Biden on July 12, 2023, and confirmed by the U.S. Senate on January 11, 2024. "I was just informed that our Country's "Jobs Numbers" are being produced by a Biden Appointee, Dr. Erika McEntarfer, the Commissioner of Labor Statistics, who faked the Jobs Numbers before the Election to try and boost Kamala's chances of Victory," President Trump posted on Truth Social on Friday. Trump alleged that the BLS, under McEntarfer's leadership, had significantly overstated job growth figures in March 2024 by approximately 818,000 jobs, followed by additional overstatements of 112,000 jobs in August and September—just before the election. He called the discrepancies "records" and questioned their validity, stating,"No one can be that wrong?" "We need accurate Jobs Numbers. I have directed my Team to fire this Biden Political Appointee, IMMEDIATELY," Trump said. "She will be replaced with someone much more competent and qualified. Important numbers like this must be fair and accurate, they can't be manipulated for political purposes." "McEntarfer said there were only 73,000 Jobs added (a shock!) but, more importantly, that a major mistake was made by them, 258,000 Jobs downward, in the prior two months. Similar things happened in the first part of the year, always to the negative." "The Economy is BOOMING under "TRUMP" despite a Fed that also plays games, this time with Interest Rates, where they lowered them twice, and substantially, just before the Presidential Election, I assume in the hopes of getting "Kamala" elected – How did that work out? Jerome "Too Late" Powell should also be put "out to pasture." Thank you for your attention to this matter!" the president posted. Background on Dr. Erika McEntarfer Dr. McEntarfer, a labor economist with over two decades of federal government experience, was nominated by President Joe Biden on July 12, 2023, and confirmed by the U.S. Senate on January 11, 2024. Her career includes key roles at the U.S. Census Bureau, where she led research for the Longitudinal Employer-Household Dynamics program, and at the White House Council of Economic Advisers, where she advised on labor market recovery during the COVID-19 pandemic. Her research, published in leading economic journals, has focused on job loss impacts, wage rigidity, and labor market dynamics. She holds a Ph.D. in economics from Virginia Tech and a bachelor's degree from Bard College. The Bureau of Labor Statistics has not yet publicly responded to Trump's allegations.
a day ago
Could U.S. tariffs drive up drug prices? Manitoba bioscience group says it's complicated, but possible
Medicine manufacturers across Canada are on edge with the looming threat of catastrophic tariffs on pharmaceutical exports to the U.S., experts say. Earlier this month, U.S. President Donald Trump threatened to impose tariffs as high as 200 per cent on pharmaceuticals exported to the United States. Howard Lutnick, Trump's secretary of commerce, said details about the pharmaceutical tariffs would come at the end of July. The uncertainty this created is starting to reveal itself as stock prices of major pharmaceutical manufacturing companies with operations in Canada — companies like Emergent Biosolutions and Bausch Health — have declined in recent days. If a 200 per cent tariff were to be put into place then I think [pharmaceutical manufacturers] would have to potentially reconsider whether it makes sense to manufacture in Canada, says Shawn Bugden, dean of the school of pharmacy at Memorial University. So what could the impact be in Canada? Given the tariff uncertainty, it's intensely complicated, says Bugden. According to government data, the pharmaceutical industry in Canada represents two per cent (new window) of global market share, and the manufacturing portion of it alone consists of an average of 35,000 jobs since 2019. Enlarge image (new window) Andrea Ladouceur, president and chief executive officer of the Bioscience Association of Manitoba, describes the pharmaceutical industry as the cornerstone of the province's economy. Photo: CBC / Justin Fraser In Manitoba, medicine is one of the leading industries, accounting for between 30-35 per cent of the medicine manufactured in Canada, seven per cent of the province's GDP, and roughly 14,000 jobs, according to Andrea Ladouceur, president of the Bioscience Association of Manitoba. The pharmaceutical industry is the cornerstone of the Manitoba economy, said Ladouceur. If being in Canada becomes unaffordable for them, these companies are connected to the global market and moving out of Canada is not off the table. The danger of these companies leaving is multifaceted. Not only would there be the major economic impact of a shrinking key industry, but we'd also lose the security of having some of the drug supply manufactured here in Canada, according to Bugden. The reliance on international trade for essential goods like medicines has proved risky in the past. During the COVID-19 pandemic, drug shortages (new window) in Canada were not uncommon. If pharmaceutical manufacturers move operations out of the country, it will likely make Canada even more reliant on global markets than they already are: with 70 per cent of drugs imported from foreign countries, 16 per cent of which is imported from the U.S., accounting for nearly $9 billion, according to Bugden. However, Budgen's main concern is that a sizable tariff, like the 200 per cent figure touted by Trump, would undermine Canada's price control mechanisms like the Patented Medicine Prices Review Board and the pan-Canadian Pharmaceutical Alliance — which he views as major assets to Canadians. The Patented Medicine Prices Review Board — established in 1987 but amended in 2019 — is meant to (new window) ensure that the prices of patented medicines sold in Canada are not excessive. The board reviews the price of drugs and medicine and conducts hearings which may result in orders to reduce prices to a non-excessive level, according to guidelines listed on their website. Shawn Bugden, dean of the school of pharmacy at Memorial University, says if Canadian pharmaceutical companies are hurt by tariffs on imports to the U.S., it could have an impact on the supply of some medicines in Canada. Photo: Submitted by Shawn Bugden Bugden says that as an unintended consequence, implementing such a substantial tariff would likely raise the cost of manufacturing drugs and medicine globally, in turn applying pressure on the review board to break their own rules and allow for higher-priced drugs. The Americans have been transparent, they say they have the highest drug prices in the world, we want to lower them, but we're not going to lower them, which is what they should do and they have the ability to do, we're instead going to try and make everybody else pay higher prices so that it allows our prices to go down, said Bugden. As things stand, many pharmaceutical companies are waiting to see what will happen. CBC News has reached out to several pharmaceutical companies in Manitoba, but none have wanted to comment given the uncertainty of the situation they're facing. Ladouceur says they're fearful that tariffs may force them to increase their prices. At the end of the day, any increase in cost will be passed on to the consumer, says Ladouceur. And so for these companies it is a very hard spot because they know it may put them out of reach for the consumer, and having medicines are key to having a healthy life and sometimes save a life, so they are really concerned their products will become unaffordable for those that need them most. Trump has said that there would be a period — a year, or a year and a half after a tariff would be imposed for companies to get their act together. In light of that, Bugden doesn't think the end consumer will be paying the price for at least a year. I don't think consumers need to worry about the prices changing tomorrow, said Bugden. Keep calm and carry on, don't think you need to run to the drug store and fill up your prescriptions. I'm confident in the institutions we have in Canada to do the best job possible to maintain pricing and accessibility for Canadians, said Bugden.
